Miles White - 2010 CEO Pay

Miles White - Abbott

Miles White, Abbott CEO

Total Compensation: $25.6 million

Details: After a rough year of declining company stock prices and FDA pressure that delayed new drug approvals, Abbott CEO and Chairman Miles White saw his total 2010 pay drop 2.5 percent to $25.6 million from 2009's $26.2 million. Although he received a two percent raise in base salary--to $1.89 million--White's stock awards took a significant 12 percent hit, accounting for the majority of his lost compensation.

The company is showing promise with its first quarter earnings in 2011, with an 18 percent rise in sales, in part thanks to its arthritis drug Humira. Its global revenue increased by 17.4 percent to $9.04 billion.

Abbott Labs News:
Abbott: Kaletra HIV med 'clobbered' by rivals
Abbott merges U.S., foreign pharma units under new chief
Abbott to axe another 1,900 jobs
Jury: Abbott breached GSK deal, but not competition law

Miles White - 2010 CEO Pay
Read more on

Suggested Articles

While Lilly's 2018 launch Emgality is approved to prevent migraines, Reyvow is intended to treat them as they occur.

ICER's new draft review of RA drugs takes a different approach, reflecting how physicians treat the disease and the time horizon that's considered.

Johnson & Johnson is facing multibillion-dollar liabilities in thousands of talc and opioid cases. But that's not such a bad thing, one analyst said.